Skip to content
Back to feed
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedAnimal studyLaboratoryPublished in a peer-reviewed journal

Mice in Cuprizone Model of Oligodendrocyte Death and Myelin Loss

Researchers used the cuprizone model to study how demyelination and oligodendrocyte death occur, revealing that remyelination is often impaired in MS lesions due to quick recovery from cuprizone-induced damage.

Most relevant to
—
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
Human efficacy
Not yet tested in people
Mechanism
Not reported
Evidence strength
Early – laboratory or animal research
Outcome
Not reported

Results in cells or animals often do not carry over to people with MS.

Why it matters

Understanding the cuprizone model is important for investigating mechanisms behind demyelination and potential therapies for MS, yet it does not fully replicate the complexities of inflammation in human MS.

What this does not prove

The cuprizone model recovers too quickly and does not adequately represent the inflammatory processes that inhibit remyelination in MS.

Next milestone

No next milestone was established from the available source.

Study facts
Study design
Laboratory
Participants / samples
Not reported
Randomised
Not reported
Controlled
Not reported
Primary endpoint met
Not reported
Relevant MS type
Not reported
Publication date
Not reported
Evidence reviewed
Abstract only
Regulatory approval
Not reported
Research areas
Remyelination, Other
Biological target
Not reported
Pathway
Not reported
Population
Not reported
Size of effect
Not reported
Secondary endpoints
Not reported
MRI endpoints
Not reported
Biomarkers
Not reported
Safety
Not reported

Original sources

Supporting passages (9)
study designPublication types: Journal Article
subjectsMeSH terms: Animals; Cuprizone; Remyelination; Multiple Sclerosis; Mice; Demyelinating Diseases; Disease Models, Animal; Oligodendroglia; Adoptive Transfer; Myelin Sheath; CD4-Positive T-Lymphocytes
speciesMeSH terms: Animals; Cuprizone; Remyelination; Multiple Sclerosis; Mice; Demyelinating Diseases; Disease Models, Animal; Oligodendroglia; Adoptive Transfer; Myelin Sheath; CD4-Positive T-Lymphocytes
peer reviewedJournal: Methods in molecular biology (Clifton, N.J.)
research categoriesThis chapter provides detailed protocols for the cuprizone and ATCup paradigms, including immune cell generation and transfer, tissue processing, and quantitative histology.
findingsThe cuprizone model is one of the most widely used demyelination models for studying oligodendrocyte death, myelin loss, and spontaneous remyelination.
limitationsRemyelination is often impaired in MS lesions, and because cuprizone-induced demyelination often recovers quickly, it does not model inflammation-mediated inhibition of remyelination.
peer reviewedPublication types: Journal Article
human efficacyMeSH terms: Animals; Cuprizone; Remyelination; Multiple Sclerosis; Mice; Demyelinating Diseases; Disease Models, Animal; Oligodendroglia; Adoptive Transfer; Myelin Sheath; CD4-Positive T-Lymphocytes

AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.

0

Discussion 0 comments

Log in or join to comment.